What after David O’toole’s Insider Acquisition of Opiant Pharmaceuticals, Inc. (OPNT) Stock?; Weitz Investment Management Lowered Mastercard (MA) Stake

May 17, 2018 - By Martha Paddon

Mastercard Incorporated (NYSE:MA) Logo

Weitz Investment Management Inc decreased Mastercard Incorporated (MA) stake by 5.43% reported in 2017Q4 SEC filing. Weitz Investment Management Inc sold 38,510 shares as Mastercard Incorporated (MA)’s stock rose 14.37%. The Weitz Investment Management Inc holds 671,134 shares with $101.58 million value, down from 709,644 last quarter. Mastercard Incorporated now has $200.84B valuation. The stock increased 0.20% or $0.38 during the last trading session, reaching $192.38. About 2.11M shares traded. Mastercard Incorporated (NYSE:MA) has risen 54.12% since May 17, 2017 and is uptrending. It has outperformed by 42.57% the S&P500.

The stock decreased 7.32% or $1.28 during the last trading session, reaching $16.21. About 62,177 shares traded or 60.83% up from the average. Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT) has risen 144.32% since May 17, 2017 and is uptrending. It has outperformed by 132.77% the S&P500.

More recent Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT) news were published by: Seekingalpha.com which released: “FDA OKs first non-opioid treatment for opioid withdrawal” on May 16, 2018. Also Nasdaq.com published the news titled: “Opiant Pharmaceuticals, Inc. Reports First Quarter 2018 Financial Results and Provides Corporate Update” on May 08, 2018. Nasdaq.com‘s news article titled: “Opiant Pharmaceuticals Awarded Grant of Approximately $7.4 Million from the National Institutes of Health for ..” with publication date: April 18, 2018 was also an interesting one.

As shown in the U.S. Security & Exchange Commission, a document for the transaction of 2,000 shares of Opiant Pharmaceuticals Inc by David O’toole was filled. David O’toole is right now a Chief Financial Officer of the Pinksheet-listed company. The legal report was filled on May 16, 2018. The insider shares were acquired at average $17.0 per share, and are worth based on the market $33,900 USD. In the last month, he also obtained 3,000 shares worth approximately $56,550 USD. David now has rights to 5,000 shares accounting for 0.19% of the Company’s market cap

Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops pharmacological treatments for substance use, addictive and eating disorders. The company has market cap of $43.72 million. The firm offers NARCAN nasal spray, a treatment to reverse opioid overdoses. It has a 21.79 P/E ratio. The Company’s pipeline of product candidates includes treatments for eating disorders, including bulimia nervosa and binge eating disorders, alcohol use disorders, a long term treatment to prevent relapse for patients with opioid use disorders, cocaine use disorders, and a heroin vaccine.

Investors sentiment increased to 0.91 in Q4 2017. Its up 0.02, from 0.89 in 2017Q3. It increased, as 46 investors sold MA shares while 492 reduced holdings. 131 funds opened positions while 356 raised stakes. 764.78 million shares or 1.94% less from 779.91 million shares in 2017Q3 were reported. Veritas Invest Mngmt Limited Liability Partnership accumulated 8.17% or 389,030 shares. Wellington Mngmt Group Llp accumulated 0.2% or 5.93M shares. Morgan Stanley, a New York-based fund reported 13.03M shares. Raub Brock Capital LP holds 4.86% or 129,730 shares in its portfolio. Oakworth Inc has invested 0.06% in Mastercard Incorporated (NYSE:MA). Toth Financial Advisory owns 18,907 shares or 0.68% of their US portfolio. Menora Mivtachim Holding Ltd holds 2.16% or 369,280 shares in its portfolio. Haverford Fincl reported 4.81% of its portfolio in Mastercard Incorporated (NYSE:MA). Verition Fund Mgmt Ltd invested 0.16% in Mastercard Incorporated (NYSE:MA). The New York-based Amalgamated Bancshares has invested 0.51% in Mastercard Incorporated (NYSE:MA). Davenport And Ltd Llc has invested 0.63% in Mastercard Incorporated (NYSE:MA). Benin Corp invested in 0.16% or 2,610 shares. Peak6 Invests Limited Partnership has invested 0.15% of its portfolio in Mastercard Incorporated (NYSE:MA). Middleton Com Ma stated it has 0.07% in Mastercard Incorporated (NYSE:MA). Blackhill Capital has 20,000 shares.

More notable recent Mastercard Incorporated (NYSE:MA) news were published by: Seekingalpha.com which released: “Mastercard: Is It Overvalued?” on May 16, 2018, also Seekingalpha.com with their article: “Mastercard’s(MA) CEO Ajay Banga Presents at JP Morgan Global Technology, Media & Communications Brokers …” published on May 16, 2018, Seekingalpha.com published: “By The Numbers: Should You Buy Mastercard Stock?” on April 26, 2018. More interesting news about Mastercard Incorporated (NYSE:MA) were released by: Seekingalpha.com and their article: “Oakmark Global Select Fund: Q1 2018” published on April 23, 2018 as well as Seekingalpha.com‘s news article titled: “Mastercard, Inc. 2018 Q1 – Results – Earnings Call Slides” with publication date: May 02, 2018.

Among 40 analysts covering Mastercard Incorporated (NYSE:MA), 36 have Buy rating, 0 Sell and 4 Hold. Therefore 90% are positive. Mastercard Incorporated has $212.0 highest and $29 lowest target. $166.86’s average target is -13.27% below currents $192.38 stock price. Mastercard Incorporated had 130 analyst reports since July 21, 2015 according to SRatingsIntel. The firm has “Equal-Weight” rating given on Thursday, October 20 by Barclays Capital. The rating was maintained by Robert W. Baird on Thursday, February 1 with “Buy”. KeyBanc Capital Markets maintained Mastercard Incorporated (NYSE:MA) on Thursday, September 7 with “Buy” rating. The rating was downgraded by S&P Research to “Hold” on Friday, October 30. The rating was maintained by Wells Fargo with “Buy” on Tuesday, January 9. The company was downgraded on Thursday, January 4 by RBC Capital Markets. The stock of Mastercard Incorporated (NYSE:MA) earned “Buy” rating by KeyBanc Capital Markets on Wednesday, August 30. The stock of Mastercard Incorporated (NYSE:MA) earned “Buy” rating by Mizuho on Thursday, January 4. The firm has “Neutral” rating by Wedbush given on Friday, October 30. RBC Capital Markets maintained Mastercard Incorporated (NYSE:MA) on Wednesday, February 1 with “Top Pick” rating.

Weitz Investment Management Inc increased Aci Worldwide Inc (NASDAQ:ACIW) stake by 85,000 shares to 350,000 valued at $7.94M in 2017Q4. It also upped Danaher Corp Del (NYSE:DHR) stake by 30,000 shares and now owns 239,870 shares. Redwood Tr Inc (NYSE:RWT) was raised too.

Analysts await Mastercard Incorporated (NYSE:MA) to report earnings on July, 26. They expect $1.54 EPS, up 40.00% or $0.44 from last year’s $1.1 per share. MA’s profit will be $1.61B for 31.23 P/E if the $1.54 EPS becomes a reality. After $1.50 actual EPS reported by Mastercard Incorporated for the previous quarter, Wall Street now forecasts 2.67% EPS growth.

Mastercard Incorporated (NYSE:MA) Institutional Positions Chart